Electromedical Technologies annual stock-based compensation
2019
2020
2021
2022
2023
Electromedical Technologies Stock-Based Compensation Growth & History (EMED)
Electromedical Technologies's stock-based compensation was $715,000 for fiscal 2023.
View full Electromedical Technologies company overviewElectromedical Technologies annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $715,000 | $205,397 | +40.31% |
| 2022 | 2022-12-31 | $509,603 | −$2.1M | −80.62% |
| 2021 | 2021-12-31 | $2.6M | $407,288 | +18.32% |
| 2020 | 2020-12-31 | $2.2M | $1.4M | +177.41% |
| 2019 | 2019-12-31 | $801,287 | — | — |
Electromedical Technologies quarterly stock-based compensation
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | $0 | −$25,000 | — |
| Q3 2023 | 2023-09-30 | $0 | −$78,000 | — |
| Q2 2023 | 2023-06-30 | $0 | −$45,000 | — |
| Q1 2023 | 2023-03-31 | $715,000 | $353,397 | +97.73% |
| Q4 2022 | 2022-12-31 | $25,000 | −$1.2M | −97.95% |
| Q3 2022 | 2022-09-30 | $78,000 | $78,000 | — |
| Q2 2022 | 2022-06-30 | $45,000 | −$65,400 | −59.24% |
| Q1 2022 | 2022-03-31 | $361,603 | −$937,124 | −72.16% |
| Q4 2021 | 2021-12-31 | $1.2M | — | — |
| Q3 2021 | 2021-09-30 | $0 | −$1.8M | — |
| Q2 2021 | 2021-06-30 | $110,400 | −$532,230 | −82.82% |
| Q1 2021 | 2021-03-31 | $1.3M | $1.0M | +339.85% |
| Q3 2020 | 2020-09-30 | $1.8M | $1.8M | +2812.36% |
| Q2 2020 | 2020-06-30 | $642,630 | $601,942 | +1479.41% |
| Q1 2020 | 2020-03-31 | $295,265 | — | — |
| Q3 2019 | 2019-09-30 | $62,628 | — | — |
| Q2 2019 | 2019-06-30 | $40,688 | — | — |
Electromedical Technologies stock-based compensation trends
Between the periods ended 2019-12-31 and 2023-12-31, Electromedical Technologies's stock-based compensation decreased from $801,287 to $715,000, a change of −$86,287. The latest reported quarter, Q4 2023, shows $0.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Electromedical Technologies source filings ↗